GSK PLC (GSK)
41.16
+0.57
(+1.40%)
USD |
NYSE |
Apr 23, 13:53
GSK Profit Margin (Quarterly): 4.35% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 4.35% |
| September 30, 2023 | 17.97% |
| June 30, 2023 | 22.62% |
| March 31, 2023 | 21.44% |
| December 31, 2022 | 20.27% |
| September 30, 2022 | |
| June 30, 2022 | 12.09% |
| March 31, 2022 | 25.06% |
| December 31, 2021 | 3.10% |
| September 30, 2021 | 20.64% |
| June 30, 2021 | 23.90% |
| March 31, 2021 | 14.46% |
| December 31, 2020 | -67.30% |
| September 30, 2020 | 14.39% |
| June 30, 2020 | 29.68% |
| March 31, 2020 | 17.22% |
| December 31, 2019 | 14.60% |
| September 30, 2019 | 16.54% |
| June 30, 2019 | 12.34% |
| March 31, 2019 | 10.83% |
| December 31, 2018 | 14.82% |
| September 30, 2018 | 17.52% |
| June 30, 2018 | 6.03% |
| March 31, 2018 | 7.60% |
| December 31, 2017 | -7.15% |
| Date | Value |
|---|---|
| September 30, 2017 | 15.45% |
| June 30, 2017 | -2.46% |
| March 31, 2017 | 14.17% |
| December 31, 2016 | 3.39% |
| September 30, 2016 | 10.71% |
| June 30, 2016 | -6.66% |
| March 31, 2016 | 4.53% |
| December 31, 2015 | -5.63% |
| September 30, 2015 | 8.78% |
| June 30, 2015 | 2.53% |
| March 31, 2015 | |
| December 31, 2014 | 16.70% |
| September 30, 2014 | 7.10% |
| June 30, 2014 | 11.76% |
| March 31, 2014 | 11.90% |
| December 31, 2013 | 35.64% |
| September 30, 2013 | 14.88% |
| June 30, 2013 | 15.79% |
| March 31, 2013 | 14.85% |
| December 31, 2012 | 12.47% |
| September 30, 2012 | 16.93% |
| June 30, 2012 | 19.16% |
| March 31, 2012 | 19.70% |
| December 31, 2011 | 17.94% |
| September 30, 2011 | 19.40% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-67.30%
Minimum
Dec 2020
29.68%
Maximum
Jun 2020
12.41%
Average
16.88%
Median
Profit Margin (Quarterly) Benchmarks
| AstraZeneca PLC | 7.98% |
| Haleon PLC | -0.11% |
| Novo Nordisk A/S | 33.35% |
| Pfizer Inc | -23.64% |
| Sanofi SA | -4.55% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 41.85% |
| Return on Assets | 8.29% |
| Return on Invested Capital | 15.54% |
| Gross Profit Margin (Quarterly) | 69.97% |
| Operating Margin (Quarterly) | 14.57% |
| Return on Net Operating Assets | 11.15% |